Editorial: Recent developments in pancreatic cancer radiotherapy, vol II
2024

Recent Developments in Pancreatic Cancer Radiotherapy

Sample size: 723 Editorial Evidence: moderate

Author Information

Author(s): Pontoriero Antonio, Ferini Gianluca

Primary Institution: University of Messina

Conclusion

The integration of radiation therapy with chemotherapy shows promise in improving survival outcomes for patients with pancreatic cancer, but further research is needed to optimize treatment strategies.

Supporting Evidence

  • Neoadjuvant therapy followed by surgical resection improves overall survival compared to immediate resection.
  • Stereotactic Body Radiotherapy (SBRT) may enhance local tumor control and survival benefits.
  • Combining immunotherapy with radiation therapy could improve treatment responses in pancreatic cancer.

Takeaway

This study looks at new ways to treat pancreatic cancer using radiation therapy, which can help patients live longer and feel better, but more research is needed to find the best methods.

Methodology

The research topic reviews various studies on the effectiveness of radiation therapy combined with chemotherapy for pancreatic cancer.

Limitations

The findings may vary due to different methods and patient classifications used in the studies reviewed.

Participant Demographics

The studies included patients with locally advanced and metastatic pancreatic cancer, with a focus on various treatment approaches.

Statistical Information

Confidence Interval

95% CI: 13.2-20.6

Digital Object Identifier (DOI)

10.3389/fonc.2024.1541855

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication